{"id":"gst-hg131","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"GST-HG131 works by inhibiting the interaction between HIF-1α and p300, thereby reducing the transcription of genes involved in angiogenesis and tumor growth.","oneSentence":"GST-HG131 is a small molecule targeting the HIF-1α pathway.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:40:11.429Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Advanced solid tumors"}]},"trialDetails":[{"nctId":"NCT06263959","phase":"PHASE2","title":"A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B","status":"RECRUITING","sponsor":"Fujian Akeylink Biotechnology Co., Ltd.","startDate":"2023-12-26","conditions":"Chronic Hepatitis B","enrollment":45},{"nctId":"NCT04499443","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets","status":"UNKNOWN","sponsor":"Fujian Cosunter Pharmaceutical Co. Ltd","startDate":"2020-08-18","conditions":"Hepatitis B","enrollment":124}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"GST-HG131","genericName":"GST-HG131","companyName":"Fujian Akeylink Biotechnology Co., Ltd.","companyId":"fujian-akeylink-biotechnology-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"GST-HG131 is a small molecule targeting the HIF-1α pathway. Used for Advanced solid tumors.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}